STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Non-cash Compensation Related to Equity Awards

Non-cash compensation related to equity awards is included in the following line items in the accompanying consolidated statements of operations and comprehensive income (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Cost of revenue	$	169	$	58	$	274	$	28
Selling and marketing expense	925		678		1,526		1,335
General and administrative expense	3,282		3,492		6,003		11,863
Product development	828		739		1,461		1,608
Restructuring and severance	1,012		195		1,012		255
Total non-cash compensation	$	6,216	$	5,162	$	10,276	$	15,089

Schedule of Changes in Outstanding Stock Options

A summary of changes in outstanding stock options is as follows:


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value(a)
		(per option)		(in years)	(in thousands)
Options outstanding at January 1, 2026	359,477	$	228.86
Granted	—	—
Exercised	—	—
Forfeited	—	—
Expired	(33,655)	135.43
Options outstanding at June 30, 2026	325,822	238.51		1.84	$	—
Options exercisable at June 30, 2026	325,822	$	238.51	1.84	$	—

(a)The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company's closing stock price of $44.29 on the last trading day of the quarter ended June 30, 2026 and the exercise price, multiplied by the number of shares covered by in-the-money options) that would have been received by the option holder had the option holder exercised these options on June 30, 2026. The intrinsic value changes based on the market value of the Company's common stock.

Schedule of Changes in Outstanding Stock Options with Market Conditions

A summary of changes in outstanding stock options with market conditions at target is as follows:


	Number of Options with Market Conditions	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value(a)
		(per option)		(in years)	(in thousands)
Options outstanding at January 1, 2026	481,669	$	195.10
Granted	—	—
Exercised	—	—
Forfeited	—	—
Expired	—	—
Options outstanding at June 30, 2026	481,669	195.10		0.28	$	—
Options exercisable at June 30, 2026	481,669	$	195.10	0.28	$	—

Schedule of Changes in Outstanding Nonvested Restricted Stock Units and Restricted Stock Units with Market Conditions

A summary of changes in outstanding nonvested restricted stock units (“RSUs”) is as follows:


	RSUs
	Number of Units	Weighted Average Grant Date Fair Value
		(per unit)
Nonvested at January 1, 2026	720,460	$	41.50
Granted	545,000	44.80
Vested	(337,091)	39.94
Forfeited	(34,079)	42.77
Nonvested at June 30, 2026	894,290	$	44.05

A summary of changes in outstanding nonvested RSUs with performance conditions is as follows:


	RSUs with Market Conditions (a)
	Number of Units	Weighted Average Grant Date Fair Value
		(per unit)
Nonvested at January 1, 2026	79,000	$	38.39
Granted	62,800	29.36
Vested	(5,000)	36.25
Forfeited	—	—
Nonvested at June 30, 2026	136,800	$	34.32

(a)During the six months ended June 30, 2026, the Company granted RSUs with market conditions that will vest if the Company's 90 trading day average closing stock price equals or exceeds certain price hurdles ($69.15, $83.85 and $98.55) during the performance period of March 5, 2026 to March 5, 2030. Upon achievement of each price hurdle, one-half of the awards will vest upon the later of the achievement date or the one-year anniversary of the grant date, and the other half of the awards will vest on the first anniversary of the achievement date.

Schedule of RSUs with Market Conditions Valuation Assumptions

For purposes of determining stock-based compensation expense, the weighted average grant date fair value per share of the RSUs with market conditions was estimated using the Monte Carlo simulation model, which requires the use of various key assumptions.


	Six Months Ended June 30,
	2026		2025
Expected term (1)	4.04 years		4.00 years
Expected volatility (2)	76.84	%	74.09	%
Risk-free interest rate (3)	3.55	%	3.91	%
Expected dividend (4)	—		—

(1)The expected term of RSUs with market conditions granted was calculated using the respective performance period plus any time-based vesting requirement.

(2)The expected volatility rate is based on the historical volatility of the Company's common stock.

(3)The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the awards in effect at the grant date.

(4)For all RSUs with market conditions granted, no dividends are expected to be paid over the contractual term of the RSUs, resulting in a zero expected dividend rate.

Schedule of Employee Stock Purchase Plan Valuation Assumptions

For purposes of determining stock-based compensation expense, the grant date fair value per share estimated using the Black-Scholes option pricing model required the use of the following key assumptions:


	Six Months Ended June 30,
	2026	2025
Expected term (1)	0.50 years	0.50 years
Expected dividend (2)	—	—
Expected volatility (3)	55%	71%
Risk-free interest rate (4)	3.58%	4.24%

(1)The expected term was calculated using the time period between the grant date and the purchase date.

(2)No dividends are expected to be paid, resulting in a zero expected dividend rate.

(3)The expected volatility rate is based on the historical volatility of the Company's common stock.

(4)The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the employee stock purchase rights in effect at the grant date.